Advanced Cut Stack — Core
Auto-generated based on evidence scores as of 2026-02-21. Compounds selected by evidence ranking with interaction safety checks. Evidence-prioritized protocol focused on stronger-researched compounds for this goal. Composite evidence score: 73.3/100. Included: LGD-4033, Survodutide, Berberine, Citrulline Malate, Magnesium Glycinate, Beta-Alanine.
Compounds
| # | Compound | Dose |
|---|---|---|
| 1 | LGD-4033 Low-dose anabolic for muscle tissue preservation in caloric deficit | 10 mg |
| 2 | Survodutide Primary fat loss agent driving appetite control and energy expenditure | 4.8 mg |
| 3 | Berberine Secondary metabolic agent supporting insulin sensitivity and fat oxidation | 1000 mg |
| 4 | Citrulline Malate Foundational compound preserving muscle function during the cut | 8000 mg |
| 5 | Magnesium Glycinate Adaptogen/sleep compound counteracting caloric deficit stress and cortisol | 400 mg |
| 6 | Beta-Alanine Foundational health support for cardiovascular and metabolic function | 3200 mg |
Interactions2 found
Beta-Alanine + Citrulline MalateSynergistic
Citrulline improves blood flow and reduces ammonia-driven fatigue; beta-alanine buffers lactic acid; together address multiple fatigue pathways
Citrulline Malate + Beta-AlanineSynergistic
Citrulline improves O2 delivery and reduces ammonia fatigue; beta-alanine buffers lactic acid; complementary pre-workout fatigue reduction
Created by CompoundAtlas AI · 0 cycles run